Login / Signup

Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery.

Tony GeJean-Christophe Cintrat
Published in: Pharmaceuticals (Basel, Switzerland) (2021)
Heterocyclic amino derivatives have been extensively synthesized and validated as potent bioactive compounds, and nowadays, numerous marketed drugs share these scaffolds, from very simple structures (monoamino, monocyclic compounds) to much more complex molecules (polycyclic derivatives with two or more nitrogen atoms within the (fused) rings). In a constant quest for new chemical entities in drug discovery, a few novel heterocycles have emerged in recent years as promising building blocks for the obtainment of bioactive modulators. In this context, pyrrolotriazinones have attracted attention, and some show promising biological activities. Here, we offer an extensive review of pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one and pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one, describing their biological properties en route to drug discovery.
Keyphrases
  • drug discovery
  • tissue engineering
  • small molecule
  • working memory
  • structure activity relationship
  • oxide nanoparticles